Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Current Assets (2023 - 2026)

BioAge Labs' Current Assets history spans 3 years, with the latest figure at $286.8 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 19.69% to $286.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $286.8 million, a 19.69% decrease, with the full-year FY2025 number at $286.8 million, down 19.69% from a year prior.
  • Current Assets hit $286.8 million in Q4 2025 for BioAge Labs, down from $290.8 million in the prior quarter.
  • Over the last five years, Current Assets for BIOA hit a ceiling of $357.1 million in Q4 2024 and a floor of $25.3 million in Q4 2023.
  • Historically, Current Assets has averaged $274.7 million across 3 years, with a median of $301.7 million in 2025.
  • Biggest five-year swings in Current Assets: skyrocketed 1311.14% in 2024 and later dropped 19.69% in 2025.
  • Tracing BIOA's Current Assets over 3 years: stood at $25.3 million in 2023, then skyrocketed by 1311.14% to $357.1 million in 2024, then dropped by 19.69% to $286.8 million in 2025.
  • Business Quant data shows Current Assets for BIOA at $286.8 million in Q4 2025, $290.8 million in Q3 2025, and $301.7 million in Q2 2025.